Richard Knight is the director and co-founder at ApconiX, where they lead a consultancy specializing in innovative nonclinical toxicology solutions for the pharmaceutical and biotech industries. With a career that includes significant roles at Zeneca Pharmaceuticals and AstraZeneca UK, Richard accumulated extensive experience in safety evaluation across various therapeutic areas, particularly in oncology. They hold a BSc (Hons) in Biomedical Sciences (Pharmacology and Toxicology) from the University of Bradford, a PhD from the University of Leeds, and completed a post-doc fellowship at UCLA. Since establishing ApconiX in 2016, Richard has focused on advancing drug discovery and development through tailored toxicology strategies and state-of-the-art laboratory services.
This person is not in the org chart
This person is not in any teams
This person is not in any offices